Overall SOX9 expression was significantly different between the four brain regions whether in AD or control tissue, however, this was more prominent in AD tissue (p<0.001) compared to control tissue (p<0.01) (Figure 2). This evidence concerns the gene SOX9 and Alzheimer disease.